Cellular preservation therapy in acute myocardial infarction

Am J Physiol Heart Circ Physiol. 2009 Mar;296(3):H563-5. doi: 10.1152/ajpheart.00066.2009. Epub 2009 Feb 6.
No abstract available

Publication types

  • Editorial
  • Kommentar

MeSH terms

  • Adenoviridae / genetics
  • Animals
  • Apoptosis / drug effects
  • Apoptosis / genetics
  • Autophagy
  • Cardiotonic Agents / pharmacology*
  • Cell Proliferation / drug effects
  • Combined Modality Therapy
  • Fibroblasts / drug effects
  • Fibroblasts / pathology
  • Fibrosis
  • Genetic Therapy*
  • Genetic Vectors
  • Granulation Tissue / drug effects
  • Granulation Tissue / pathology
  • Granulocyte Colony-Stimulating Factor / pharmacology
  • Heart Failure / etiology
  • Heart Failure / genetics
  • Heart Failure / pathology
  • Heart Failure / therapy*
  • Humans
  • Lenograstim
  • Myocardial Infarction / complications
  • Myocardial Infarction / genetics
  • Myocardial Infarction / pathology
  • Myocardial Infarction / therapy*
  • Myocardium / metabolism
  • Myocardium / pathology*
  • Necrosis
  • Recombinant Proteins / pharmacology
  • Regeneration* / drug effects
  • Regeneration* / genetics
  • Stem Cells / drug effects
  • Time Factors
  • fas Receptor / genetics
  • fas Receptor / metabolism

Substances

  • Cardiotonic Agents
  • Fas protein, mouse
  • Recombinant Proteins
  • fas Receptor
  • Granulocyte Colony-Stimulating Factor
  • Lenograstim